In-PharmaTechnologist's Pharma Phacts series brings you a 90 second micro-dose of the latest discoveries and science news affecting the pharmaceutical manufacturing, processing and packaging industries.
GSK, Genentech, BIO and PDA have stated that it is “unnecessarily burdensome” for pandemic production plans to conform to parts of 21 CFR and requested that the FDA revises its draft guidance...